Literature DB >> 2232044

Treatment of speech and voice disorders with botulinum toxin.

C L Ludlow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2232044

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie
Journal:  J Commun Disord       Date:  2005 Sep-Oct       Impact factor: 2.288

Review 2.  New concepts in botulinum toxin therapy.

Authors:  G E Borodic; L B Pearce
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

3.  Spasmodic dysphonia and laryngeal botulinum toxin injection.

Authors:  M E Smith
Journal:  West J Med       Date:  1993-07

4.  Spasmodic dysphonia combined with insufficient glottic closure by phonation.

Authors:  Z Kaszás; G Lichtenberger; K Mészáros; J Falvai
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-04-23       Impact factor: 2.503

Review 5.  Managing Essential Tremor.

Authors:  Franziska Hopfner; Günther Deuschl
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 6.088
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.